It is common practice to begin anticoagulant treatment of deep-vein thrombosis with a 10-day course of intravenous heparin, with warfarin added on day 5 to 10 and continued for several months. We performed a randomized, double-blind trial comparing a shorter course of continuous intravenous heparin (5 days, with warfarin sodium begun on the first day) with the conventional 10-day course of heparin (with warfarin sodium begun on the fifth day) in the initial treatment of 199 patients with acute proximal venous thrombosis documented by venography. The frequency of objectively documented recurrent venous thromboembolism was low and essentially the same in the two groups (7.1 percent in the short-course group vs. 7.0 percent in the long-course group). Because the observed difference between the groups was 0.1 percent in favor of the long-course group, it is unlikely (P less than 0.05) that a true difference in favor of this group would be greater than 7.5 percent; the difference could be as much as 7.3 percent in favor of the short-course group. Major bleeding episodes were infrequent, and the rate was similar in both groups. We conclude that a five-day course of heparin is as effective as a 10-day course in treating deep venous thrombosis. Furthermore, using the shorter course would permit earlier discharge from the hospital and thus offer substantial cost savings.
Source Information
Division of General Internal Medicine, University of Calgary, Alb., Canada.
This article has been cited by other articles:
Authors/Task Force Members, , Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galie, N., Pruszczyk, P., Bengel, F., Brady, A. J.B., Ferreira, D., Janssens, U., Klepetko, W., Mayer, E., Remy-Jardin, M., Bassand, J.-P., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Zamorano, J.-L., Andreotti, F., Ascherman, M., Athanassopoulos, G., De Sutter, J., Fitzmaurice, D., Forster, T., Heras, M., Jondeau, G., Kjeldsen, K., Knuuti, J., Lang, I., Lenzen, M., Lopez-Sendon, J., Nihoyannopoulos, P., Perez Isla, L., Schwehr, U., Torraca, L., Vachiery, J.-L.
(2008). Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J
29: 2276-2315
[Full Text]
Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N.
(2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 257S-298S
[Abstract][Full Text]
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., Comerota, A. J.
(2008). Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 454S-545S
[Abstract][Full Text]
Campbell, I A, Bentley, D P, Prescott, R J, Routledge, P A, Shetty, H G M, Williamson, I J
(2007). Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ
334: 674-674
[Abstract][Full Text]
Krivak, T. C., Zorn, K. K.
(2007). Venous Thromboembolism in Obstetrics and Gynecology. Obstet Gynecol
109: 761-777
[Abstract][Full Text]
Kearon, C., Ginsberg, J. S., Julian, J. A., Douketis, J., Solymoss, S., Ockelford, P., Jackson, S., Turpie, A. G., MacKinnon, B., Hirsh, J., Gent, M., for the Fixed-Dose Heparin (FIDO) Investigators,
(2006). Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.. JAMA
296: 935-942
[Abstract][Full Text]
Eckman, M. H.
(2005). "Bridging On the River Kwai": The Perioperative Management of Anticoagulation Therapy. Med Decis Making
25: 370-373
McGuire, M., Dobesh, P. P.
(2004). Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism. Journal of Pharmacy Practice
17: 289-307
[Abstract]
Levine, M. N., Raskob, G., Beyth, R. J., Kearon, C., Schulman, S.
(2004). Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 287S-310S
[Abstract][Full Text]
Buller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., Raskob, G. E.
(2004). Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 401S-428S
[Abstract][Full Text]
McRae, S. J., Ginsberg, J. S.
(2004). Initial Treatment of Venous Thromboembolism. Circulation
110: I-3-I-9
[Abstract][Full Text]
Linkins, L.-A., Choi, P. T., Douketis, J. D.
(2003). Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism: A Meta-Analysis. ANN INTERN MED
139: 893-900
[Abstract][Full Text]
van Dongen, C. J. J., Vink, R., Hutten, B. A., Buller, H. R., Prins, M. H.
(2003). The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis. Arch Intern Med
163: 1285-1293
[Abstract][Full Text]
Dunn, A. S., Turpie, A. G. G.
(2003). Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review. Arch Intern Med
163: 901-908
[Abstract][Full Text]
Hyers, T. M.
(2003). Management of Venous Thromboembolism: Past, Present, and Future. Arch Intern Med
163: 759-768
[Abstract][Full Text]
Schafer, A. I., Levine, M. N., Konkle, B. A., Kearon, C.
(2003). Thrombotic Disorders: Diagnosis and Treatment. ASH Education Book
2003: 520-539
[Abstract][Full Text]
Wood, K. E.
(2002). Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism. Chest
121: 877-905
[Abstract][Full Text]
Tait, R C
(2001). Anticoagulation in patients with thromboembolic disease. Thorax
56: ii30-37
[Full Text]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Arterioscler. Thromb. Vasc. Bio.
21
: e9-e9
[Full Text]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Circulation
103: 2994-3018
[Full Text]
Paterson, D. I., Schwartzman, K.
(2001). Strategies Incorporating Spiral CT for the Diagnosis of Acute Pulmonary Embolism : A Cost-effectiveness Analysis. Chest
119: 1791-1800
[Abstract][Full Text]
Breddin, H. K., Hach-Wunderle, V., Nakov, R., Kakkar, V. V., The CORTES Investigators,
(2001). Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis. NEJM
344: 626-631
[Abstract][Full Text]
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., Dalen, J. E.
(2001). Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety. Chest
119: 64S-94S
[Full Text]
Levine, M. N., Raskob, G., Landefeld, S., Kearon, C.
(2001). Hemorrhagic Complications of Anticoagulant Treatment. Chest
119: 108S-121S
[Full Text]
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., Weg, J. G.
(2001). Antithrombotic Therapy for Venous Thromboembolic Disease. Chest
119: 176S-193S
[Full Text]
Monagle, P., Michelson, A. D., Bovill, E., Andrew, M.
(2001). Antithrombotic Therapy in Children. Chest
119: 344S-370S
[Full Text]
(2000). Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J
21: 1301-1336
Gonze, M. D., Salartash, K., Sternbergh, W. C. III, Baughman, R. A., Leone-Bay, A., Money, S. R.
(2000). Orally Administered Unfractionated Heparin With Carrier Agent Is Therapeutic for Deep Venous Thrombosis. Circulation
101: 2658-2661
[Abstract][Full Text]
Hull, R. D., Raskob, G. E., Brant, R. F., Pineo, G. F., Elliott, G., Stein, P. D., Gottschalk, A., Valentine, K. A., Mah, A. F., for the American-Canadian Thrombosis Study Group,
(2000). Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary Embolism. Arch Intern Med
160: 229-236
[Abstract][Full Text]
Wakefield, T. W.
(2000). The Safety, Efficacy, and Cost Efficiency of Outpatient Treatment of Acute Deep Venous Thrombosis with Low Molecular Weight Heparin. PERSPECT VASC SURG ENDOVASC THER
13: 19-25
[Abstract]
Anand, S. S., Bates, S., Ginsberg, J. S., Levine, M., Buller, H., Prins, M., Haley, S., Kearon, C., Hirsh, J., Gent, M.
(1999). Recurrent Venous Thrombosis and Heparin Therapy: An Evaluation of the Importance of Early Activated Partial Thromboplastin Times. Arch Intern Med
159: 2029-2032
[Abstract][Full Text]
Hirko, M. K., Kasirajan, K., Turner, J. J., Rubin, J. R.
(1999). Propagation of Tibial Vein Thrombus in Patients Systemically Anticoagulated or Receiving Antiplatelet Therapy. VASC ENDOVASCULAR SURG
33: 251-256
[Abstract]
Fraser, J. D., Anderson, D. R.
(1999). Deep Venous Thrombosis: Recent Advances and Optimal Investigation with US. Radiology
211: 9-24
[Full Text]
Mewissen, M. W., Seabrook, G. R., Meissner, M. H., Cynamon, J., Labropoulos, N., Haughton, S. H.
(1999). Catheter-directed Thrombolysis for Lower Extremity Deep Venous Thrombosis: Report of a National Multicenter Registry. Radiology
211: 39-49
[Abstract][Full Text]
Caps, M. T, Meissner, M. H, Tullis, M. J, Polissar, N. L, Manzo, R. A, Zierler, B. K, Chandler, W. L, Strandness, D E. Jr
(1999). Venous thrombus stability during acute phase of therapy. Vasc Med
4: 9-14
[Abstract]
Verstraete, M.
(1999). Prevention and treatment of venous thromboembolism after major trauma. Trauma
1: 39-51
[Abstract]
Kearon, C., Johnston, M., Moffat, K., McGinnis, J., Ginsberg, J. S.
(1998). Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin. Arch Intern Med
158: 1140-1143
[Abstract][Full Text]
White, R. H., Zhou, H., Romano, P. S.
(1998). Length of Hospital Stay for Treatment of Deep Venous Thrombosis and the Incidence of Recurrent Thromboembolism. Arch Intern Med
158: 1005-1010
[Abstract][Full Text]
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., Huet, Y., Simonneau, G., The Prevention du Risque d'Embolie Pulmonaire par,
(1998). A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. NEJM
338: 409-416
[Abstract][Full Text]
Douketis, J. D., Kearon, C., Bates, S., Duku, E. K., Ginsberg, J. S.
(1998). Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism. JAMA
279: 458-462
[Abstract][Full Text]
Buller, H. R, Kraaijenhagen, R. A, Koopman, M. M.
(1998). Early discharge strategies following venous thrombosis. Vasc Med
3: 47-50
[Abstract]
Prandoni, P., Lensing, A. W., Prins, M. R
(1998). Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med
3: 57-60
[Abstract]
Crowther, M., Hirsh, J.
(1998). Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results. PERSPECT VASC SURG ENDOVASC THER
9: 91-98
[Abstract]
Valentine, K. A., Hull, R. D., Pineo, G. F.
(1998). Low-Molecular-Weight Heparin Therapy and Mortality. PERSPECT VASC SURG ENDOVASC THER
9: 99-108
[Abstract]
Becker, R. C., Ansell, J.
(1997). The Need for Long-Term Anticoagulants in Venous Thromboembolism: How Long?. CLIN APPL THROMB HEMOST
3: S8-S15
Anand, S., Ginsberg, J. S., Hirsh, J.
(1997). Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism?. CLIN APPL THROMB HEMOST
3: S64-S67
[Abstract]
Hull, R. D., Pineo, G. F.
(1997). Overview of Treatment of Venous Thromboembolism Based on Levels of Evidence. CLIN APPL THROMB HEMOST
3: S68-S71
Eby, C.
(1997). Standardization of APTT Reagents for Heparin Therapy Monitoring: Urgent or Fading Priority?. Clin. Chem.
43: 1105-1107
[Full Text]
Kearon, C., Hirsh, J.
(1997). Management of Anticoagulation before and after Elective Surgery. NEJM
336: 1506-1511
[Full Text]
Schulman, S., Granqvist, S., Holmstrom, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S.-G., Nordlander, S., Larfars, G., Leijd, B., Linder, O., Loogna, E., Walter, H., Viering, S., Hjorth, M., Boberg, J., The Duration of Anticoagulation Trial Study Group,
(1997). The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism. NEJM
336: 393-398
[Abstract][Full Text]
Diuguid, D. L.
(1997). Oral Anticoagulant Therapy for Venous Thromboembolism. NEJM
336: 433-434
[Full Text]
Ginsberg, J. S.
(1996). Management of Venous Thromboembolism. NEJM
335: 1816-1829
[Full Text]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
Koopman, M. M.W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P.M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., Bossuyt, P. M.M., de Haes, H., van den Belt, A. G.M., Sagnard, L., d'Azemar, P., Buller, H. R., The Tasman Study Group,
(1996). Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home. NEJM
334: 682-687
[Abstract][Full Text]
Schafer, A. I.
(1996). Low-Molecular-Weight Heparin -- An Opportunity for Home Treatment of Venous Thrombosis. NEJM
334: 724-726
[Full Text]
Pearson, S. D., Goulart-Fisher, D., Lee, T. H.
(1995). Critical Pathways as a Strategy for Improving Care: Problems and Potential. ANN INTERN MED
123: 941-948
[Abstract][Full Text]
Hull, R. D., Raskob, G. E., Pineo, G. F., Brant, R. F.
(1995). The Treatment of Proximal Vein Thrombosis with Subcutaneous Low-Mole Molecular-Weight Heparin Compared with Continuous Intravenous Heparin. CLIN APPL THROMB HEMOST
1: 151-159
[Abstract]
Weinmann, E. E., Salzman, E. W.
(1994). Deep-Vein Thrombosis. NEJM
331: 1630-1641
[Full Text]
Leizorovicz, A, Simonneau, G, Decousus, H, Boissel, J P
(1994). Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ
309: 299-304
[Abstract][Full Text]
Previous
